Advanced search×

[Anesthetic consultation in patients with cardiac risk].

Vincent V Piriou and Emmanuel E Marret

Rev Prat 60(9):1265-71 (2010) PMID 21328864

Version: za2963e q8zae q8zbf q8zc6 q8zd1 q8zee q8zfa q8zgf
Buy PDF

Similar articles you may find interesting…

  1. Synthesis and Biological Evaluation of Novel Bromophenol Derivatives as Carbonic Anhydrase Inhibitors.
    Yusuf Akbaba, Halis Türker Balaydın, and Deniz Ekinci

    Arch Pharm (Weinheim) (2013) PMID 23649517

    We provide an alternative synthesis of the natural bromophenol 3,4-dibromo-5-(2,3-dibromo-4,5-dihydroxybenzyl)-6-(ethoxymethyl)benzene-1,2-diol (3) and the first synthesis of (4,5-dihydroxy-2-methylphenyl)(3,4-dihydroxyphenyl)methanone (18) and its brominated derivatives 19-21. The compounds were ch...
    Buy PDF
  2. Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo.
    Fabrizio Carta, Atilla Akdemir, and Claudiu T Supuran

    J Med Chem (2013) PMID 23647428

    Dithiocarbamates (DTCs) were recently discovered as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors. A series of xanthates and a trithiocarbonate, structurally related to the DTCs, were prepared by reaction of alcohols/thiols with carbon disulfide in the presence of bases. These compo...
    Buy PDF
  3. A Novel Multi-Unit Tablet for Treating Circadian Rhythm Diseases.
    Qi Liu, Yinhua Gong, and Jiabi Zhu

    AAPS PharmSciTech (2013) PMID 23649996

    This study aimed to develop and evaluate a novel multi-unit tablet that combined a pellet with a sustained-release coating and a tablet with a pulsatile coating for the treatment of circadian rhythm diseases. The model drug, isosorbide-5-mononitrate, was sprayed on microcrystalline c...
    Buy PDF